View Article
Volume-12 Number-2, 2025 / Editorial
Agentic Artificial Intelligence (AI): Redefining the Future of Medical Research
Author:
Prof. (Dr) Sharique Ahmad
Editor-in-Chief
Era's Lucknow Medical College & Hospital,
Era University, Lucknow-226003
Abstract:
Artificial intelligence (AI) has rapidly moved from
being a passive analytical tool to an active participant in scientific
discovery. The latest evolution, agentic AI, introduces systems capable
of setting goals, planning actions, and adapting autonomously. Unlike
conventional models that merely respond to commands, agentic AI can
independently design experiments, interpret outcomes, and refine its
approach—making it an emerging partner in medical research rather than a simple
instrument.
In biomedical science, researchers constantly face
challenges of time, data overload, and integration of complex information.
Agentic AI has the potential to overcome these constraints. By continuously
analysing large and diverse datasets, it can recognize new patterns, generate
testable hypotheses, and propose innovative therapeutic directions. Such
systems can synthesize evidence across genomics, proteomics, and clinical data,
offering insights that would take human teams months to uncover.
The most immediate impact is evident in drug
discovery and translational research. Traditional drug development is slow,
costly, and uncertain. Agentic AI can automate much of the preclinical process—screening
molecules, predicting efficacy, assessing toxicity, and iterating designs in
silico. When paired with robotic laboratories, it can run high-throughput
experiments and optimize compounds in real time. Early demonstrations show that
AI-driven autonomous labs can test thousands of reactions daily, learning and
improving continuously. This capability could reduce discovery cycles from
years to weeks, profoundly changing how therapies reach patients.
In clinical research, agentic AI can
streamline trial design, recruitment, and monitoring. By integrating data from
electronic health records, wearables, and genomic sources, it can identify
appropriate patient cohorts, enhance trial diversity, and flag safety concerns
early. Its ability to analyse data continuously allows real-time adjustments
that increase trial efficiency and ethical oversight. Furthermore, AI-based
literature mining can help identify underexplored pathways or suggest novel
uses for existing drugs, expanding the scope of biomedical innovation.
Despite its promise, agentic AI introduces new ethical
and governance challenges. Autonomy blurs accountability—who is responsible
for an AI-generated hypothesis or decision? The opacity of complex algorithms
can also limit transparency and reproducibility. To ensure scientific
integrity, researchers must implement systems for algorithmic auditing, human
supervision, and detailed documentation of decision processes.
Data security and privacy are equally critical. Agentic systems rely on continuous access to
sensitive biomedical data. Protecting patient identity through federated
learning, encryption, and strict regulatory compliance will be essential.
Institutions must balance the need for open data with robust ethical safeguards
to maintain public trust.
The rise of agentic AI also demands a cultural and
educational shift. Researchers and clinicians must be trained to collaborate
effectively with autonomous systems—understanding not only the computational
principles but also the limitations and biases inherent in machine reasoning.
Policymakers, meanwhile, should design flexible regulatory frameworks that
encourage innovation while preserving ethical standards.
Ultimately, agentic AI represents a turning
point in the conduct of medical research. It offers speed, precision, and
scalability previously unimaginable, but it also requires deliberate human
guidance. The goal should not be to replace researchers, but to augment their
creativity and judgment. As these intelligent systems mature, their success
will depend on how responsibly they are integrated into scientific inquiry.
If guided by transparency and ethics, agentic AI
can become a trusted collaborator—accelerating discovery, personalizing
medicine, and deepening our understanding of disease. The partnership between
human insight and autonomous intelligence may well define the next era of
medical progress.
Download PDF
View in DOI